Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation. 2018

David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
Department of Chemistry, University of Waterloo, Waterloo, ON N2L 3G1, Canada. Electronic address: dberiashvili@edu.uwaterloo.ca.

Daptomycin is a lipopeptide antibiotic that binds and permeabilizes the cell membranes of Gram-positive bacteria. Membrane permeabilization requires both calcium and phosphatidylglycerol (PG) in the target membrane, and it correlates with the formation of an oligomer that likely comprises eight subunits, which are evenly distributed between the two membrane leaflets. In both bacterial cells and model membranes, changes in the fatty acyl composition of the membrane phospholipids can prevent permeabilization. We here used liposomes to study the effect of phospholipids containing oleoyl and other fatty acyl residues on daptomycin activity, and made the following observations: (1) Oleic acid residues inhibited permeabilization when part not only of PG, but also of other phospholipids (PC or cardiolipin). (2) When included in an otherwise daptomycin-susceptible lipid mixture, even 10% of dioleoyl lipid (DOPC) can strongly inhibit permeabilization. (3) The inhibitory effect of fatty acyl residues appears to correlate more with their chain length than with unsaturation. (4) Under all conditions tested, permeabilization coincided with octamer formation, whereas tetramers were observed on membranes that were not permeabilized. Overall, our findings further support the notion that the octamer is indeed the functional transmembrane pore, and that fatty acyl residues may prevent pore formation by preventing the alignment of tetramers across the two membrane leaflets.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D017576 Daptomycin A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA. Cubicin,Daptomycin, 9-L beta-Aspartic Acid,Deptomycin,LY-146032,Daptomycin, 9 L beta Aspartic Acid,LY 146032,LY146032

Related Publications

David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
January 2019, Antimicrobial agents and chemotherapy,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
October 2015, Biophysical journal,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
November 2014, Trends in biochemical sciences,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
February 2024, Biochemical and biophysical research communications,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
June 1978, Journal of bacteriology,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
October 2020, Biochimica et biophysica acta. Biomembranes,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
December 2016, Applied physics letters,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
January 2010, Bioscience, biotechnology, and biochemistry,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
May 1981, The Biochemical journal,
David Beriashvili, and Robert Taylor, and Braden Kralt, and Nooran Abu Mazen, and Scott D Taylor, and Michael Palmer
March 1986, The Journal of clinical investigation,
Copied contents to your clipboard!